Related Experiment Video
Updated: Jun 2, 2026

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
Published on: April 16, 2019
Acute pancreatitis associated with liraglutide
Phillip H Lee1, M David Stockton, Andrea S Franks
1College of Pharmacy, University of Tennessee Medical Center, Knoxville, TN, USA.
This case report details a probable adverse drug reaction of acute pancreatitis in a patient treated with liraglutide. Clinicians should monitor for this rare side effect, especially in patients with a history of pancreatitis.
Area of Science:
- Endocrinology
- Pharmacology
- Gastroenterology
Background:
- Liraglutide is a glucagon-like peptide-1 receptor agonist used for type 2 diabetes management.
- Pancreatitis is a known, albeit rare, potential adverse effect associated with GLP-1 receptor agonists.
- Previous clinical trials reported cases of pancreatitis with liraglutide use.
Observation:
- A 60-year-old female with type 2 diabetes developed acute pancreatitis three weeks after switching from exenatide to liraglutide.
- The patient presented with severe mid-epigastric pain and elevated serum lipase levels.
- Liraglutide was discontinued, and standard pancreatitis treatment led to symptom resolution.
Findings:
- The Naranjo scale suggests a probable drug-induced adverse reaction.
- The temporal association between liraglutide initiation and symptom onset supports a causal link.
- This represents a postmarketing case of liraglutide-associated acute pancreatitis.
Implications:
- Liraglutide should be prescribed with caution in patients with a prior history of pancreatitis.
- Healthcare providers should maintain a high index of suspicion for liraglutide-induced pancreatitis.
- Early recognition and discontinuation of liraglutide are crucial for managing this rare adverse event.
Related Concept Videos
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis II: Clinical Manifestations and Management

